Skip to main content
OpenTrials

Clinical trial condition

Smoldering Multiple Myeloma

Explore clinical trials studying Smoldering Multiple Myeloma. Study availability and eligibility vary by location and protocol.

44 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Smoldering Multiple Myeloma trial results

Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

NCT06768489

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations
  • Monash Medical Centre Clayton, Australia
  • St Vincents Hospital Melbourne Fitzroy, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Calvary Mater Newcastle Hospital Waratah, Australia
View all 16 locations
View Trial Details
Recruiting

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

NCT05469893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592

Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details
Recruiting

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

NCT06383143

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +17 more
Locations
  • Azienda Ospedaliera Policlinico Consorziale Bari, Italy
  • Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco Catania, Italy
  • Fondazione Irccs Policlinico San Matteo Pavia, Italy
  • EMATOLOGIA - Città della Scienza e Salute - Torino Torino, Italy
View Trial Details
Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT05640843

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Emory University (Data Collection Only) Atlanta, Georgia, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

European Myeloma Network (EMN) Sample Project

NCT06237803

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Myeloma, +20 more
Locations
  • Alfred Hospital Melbourne, Australia
  • KUK Linz Linz, Austria
  • Medical University Vienna Vienna, Austria
  • Department of Haematology UZ Leuven Gasthuisberg Leuven, Belgium
View all 41 locations
View Trial Details

Related conditions